| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20,906 |
19,103 |
$1.27M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,747 |
7,172 |
$731K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,837 |
1,805 |
$138K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,478 |
2,325 |
$110K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,328 |
2,254 |
$101K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,057 |
1,955 |
$87K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,304 |
1,217 |
$76K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,545 |
5,239 |
$67K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
924 |
895 |
$61K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
724 |
719 |
$56K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,579 |
1,490 |
$40K |
| 90461 |
|
579 |
574 |
$32K |
| 90686 |
|
1,617 |
1,607 |
$31K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,142 |
1,109 |
$28K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,951 |
1,898 |
$18K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
106 |
78 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
771 |
732 |
$15K |
| 90698 |
|
604 |
591 |
$12K |
| 87081 |
|
1,226 |
1,188 |
$9K |
| 90671 |
|
426 |
402 |
$9K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
117 |
110 |
$6K |
| 90680 |
|
265 |
256 |
$4K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
398 |
383 |
$4K |
| 90685 |
|
178 |
176 |
$3K |
| 90670 |
|
210 |
210 |
$3K |
| 90651 |
|
26 |
26 |
$3K |
| 90656 |
|
177 |
144 |
$2K |
| 87634 |
|
49 |
49 |
$2K |
| 90734 |
|
13 |
13 |
$2K |
| Q3014 |
Telehealth originating site facility fee |
84 |
77 |
$1K |
| 90633 |
|
79 |
77 |
$1K |
| 36416 |
|
3,873 |
3,501 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
86 |
63 |
$1K |
| 90744 |
|
44 |
43 |
$811.39 |
| 90715 |
|
42 |
42 |
$791.60 |
| 99000 |
|
236 |
230 |
$619.50 |
| 90619 |
|
31 |
31 |
$593.70 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
44 |
18 |
$590.40 |
| 97802 |
|
405 |
264 |
$289.88 |
| 99173 |
|
62 |
62 |
$265.00 |
| 99070 |
|
166 |
154 |
$257.58 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
12 |
12 |
$211.12 |
| 90660 |
|
25 |
25 |
$192.00 |
| 96127 |
|
17 |
12 |
$55.59 |
| 96160 |
|
16 |
16 |
$38.22 |
| 97803 |
|
1,157 |
631 |
$0.00 |